Jose DaRocha - Net Worth and Insider Trading
Jose DaRocha Net Worth
The estimated net worth of Jose DaRocha is at least $63,896 dollars as of 2024-09-21. Jose DaRocha is the Director, Senior Officer of Crescita Therapeutics Inc and owns about 103,058 shares of Crescita Therapeutics Inc (TSX:CTX) stock worth over $63,896. Details can be seen in Jose DaRocha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jose DaRocha has not made any transactions after 2021-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jose DaRocha
Jose DaRocha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jose DaRocha owns 1 companies in total, including Crescita Therapeutics Inc (TSX:CTX) .
Click here to see the complete history of Jose DaRocha’s form 4 insider trades.
Insider Ownership Summary of Jose DaRocha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:CTX | Crescita Therapeutics Inc | 2021-12-15 | Director & Senior Officer |
Jose DaRocha Latest Holdings Summary
Jose DaRocha currently owns a total of 1 stock. Jose DaRocha owns 103,058 shares of Crescita Therapeutics Inc (TSX:CTX) as of December 15, 2021, with a value of $63,896.
Latest Holdings of Jose DaRocha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:CTX | Crescita Therapeutics Inc | 2021-12-15 | 103,058 | 0.62 | 63,896 |
Holding Weightings of Jose DaRocha
Jose DaRocha Form 4 Trading Tracker
According to the SEC Form 4 filings, Jose DaRocha has made a total of 2 transactions in Crescita Therapeutics Inc (TSX:CTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Crescita Therapeutics Inc is the acquisition of 2,500 shares on December 15, 2021, which cost Jose DaRocha around $1,625.
Insider Trading History of Jose DaRocha
- 1
Jose DaRocha Trading Performance
GuruFocus tracks the stock performance after each of Jose DaRocha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jose DaRocha is -10.29%. GuruFocus also compares Jose DaRocha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jose DaRocha within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jose DaRocha's insider trading performs compared to the benchmark.
Jose DaRocha Ownership Network
Jose DaRocha Owned Company Details
What does Crescita Therapeutics Inc do?
Who are the key executives at Crescita Therapeutics Inc?
Jose DaRocha is the Director & Senior Officer of Crescita Therapeutics Inc. Other key executives at Crescita Therapeutics Inc include Director & Senior Officer Daniel Chicoine , Senior Officer Serge Verreault , and 10% Security Holder Knight Therapeutics Inc. .
Crescita Therapeutics Inc (TSX:CTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Crescita Therapeutics Inc (TSX:CTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Crescita Therapeutics Inc (TSX:CTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Crescita Therapeutics Inc (TSX:CTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crescita Therapeutics Inc Insider Transactions
Jose DaRocha Mailing Address
Above is the net worth, insider trading, and ownership report for Jose DaRocha. Currently GuruFocus does not have mailing address information for Jose DaRocha.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
